FY2024 EPS Estimates for UnitedHealth Group Incorporated (NYSE:UNH) Raised by Analyst

UnitedHealth Group Incorporated (NYSE:UNH) – Analysts at Leerink Partnrs increased their FY2024 earnings estimates for shares of UnitedHealth Group in a note issued to investors on Tuesday, April 16th. Leerink Partnrs analyst W. Mayo now forecasts that the healthcare conglomerate will post earnings of $27.63 per share for the year, up from their previous forecast of $27.54. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.74 per share. Leerink Partnrs also issued estimates for UnitedHealth Group’s Q4 2024 earnings at $6.59 EPS.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the prior year, the company earned $6.26 EPS. The firm’s quarterly revenue was up 8.6% on a year-over-year basis.

A number of other equities analysts have also weighed in on UNH. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Stephens reiterated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Finally, Truist Financial reiterated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Price Performance

UNH opened at $493.16 on Friday. The stock has a market cap of $454.66 billion, a P/E ratio of 30.14, a P/E/G ratio of 1.31 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a fifty day simple moving average of $488.97 and a 200 day simple moving average of $515.22.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors have recently made changes to their positions in UNH. Robbins Farley acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $25,000. Richelieu Gestion SA acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. CGC Financial Services LLC raised its stake in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the period. True Wealth Design LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $31,000. Finally, NewSquare Capital LLC increased its holdings in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.